AI assistant
INSMED Inc — Director's Dealing 2017
Jun 5, 2017
30150_dirs_2017-06-05_d119a414-658c-4efb-9783-18db2f7b46c5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2017-06-01
Reporting Person: TOMBESI PAOLO (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-01 | Stock Option | $15.60 | A | 127160 | Acquired | 2027-06-01 | Common Stock (127160) | Direct |
Footnotes
F1: In connection with the appointment of Mr. Tombesi as the Company's Chief Financial Officer, the Company granted Mr. Tombesi an option to purchase a total of 127,160 shares of the Company's common stock. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date through the fourth anniversary of the date of grant, subject to Mr. Tombesi's continued employment with the Company on each vesting date.